Tag Archives: Pfizer-BioNTech apply for EU emergency authorization for COVID-19 vaccine

FRANKFURT: Pfizer and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday. The application to the European Medicines Agency (EMA) comes after the companies applied for U.S. approval on Nov. 20, taking them a step closer to launching their vaccine. …

Read More »